The latest closing stock price for ArriVent BioPharma as of November 04, 2024 is 31.49.
An investor who bought $1,000 worth of ArriVent BioPharma stock at the IPO in 2024 would have $575 today, roughly 1 times their original investment - a 57.45% compound annual growth rate over 1 years.
The all-time high ArriVent BioPharma stock closing price was 32.17 on October 28, 2024.
The ArriVent BioPharma 52-week high stock price is 32.40, which is 2.9% above the current share price.
The ArriVent BioPharma 52-week low stock price is 14.35, which is 54.4% below the current share price.
The average ArriVent BioPharma stock price for the last 52 weeks is 21.35.
An investor who bought $1,000 worth of ArriVent BioPharma stock at the IPO in 2024 would have $575 today, roughly 1 times their original investment - a 57.45% compound annual growth rate over 1 years.
The all-time high ArriVent BioPharma stock closing price was 32.17 on October 28, 2024.
The ArriVent BioPharma 52-week high stock price is 32.40, which is 2.9% above the current share price.
The ArriVent BioPharma 52-week low stock price is 14.35, which is 54.4% below the current share price.
The average ArriVent BioPharma stock price for the last 52 weeks is 21.35.